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Snapshot technology platform.
RESULTS The AA genotype of rs2902940 SNP was associated with
an increased risk of CAD (adjusted OR ¼ 1.63, 95% CI ¼ 1.07-2.48,
P ¼ 0.023) and IS (adjusted OR ¼ 1.69, 95% CI ¼ 1.09-2.61, P ¼
0.017). The GA/AA genotype was also associated with an increased
risk of CAD (adjusted OR ¼ 1.56, 95% CI ¼ 1.04-2.32, P ¼ 0.030
for GA/AA vs. GG) and IS (adjusted OR ¼ 1.72, 95% CI ¼ 1.14-2.60,
P ¼ 0.010 for GA/AA vs. GG). Signiﬁcant interactions were
observed only in those with higher BMI, hypertension and dia-
betes (P<0.05). The subjects with GA/AA genotypes in controls
had lower serum ApoAI levels than the subjects with GG genotype
(P ¼ 0.024).
CONCLUSIONS The A allele carriers of SNP rs2902940 in the MAFB
conferred a decreased serum ApoAI levels in controls and an
increased risk of CAD and IS. The GA/AA genotypes interacted with
higher BMI, hypertension and diabetes to contribute the risk of CAD
and IS.
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OBJECTIVES This multiple-ethnic, community-based, cross-sectional
study was conducted to estimate the prevalence and distribution of
congenital heart disease (CHD) in Xinjiang, northwestern part of
China. Four major ethnics, Han, Uygur, Kazakh, and Hui Chinese in
this region were investigated during February 2010 and May 2012.
METHODS A total of 14,530 children (0-18 yr) completed the survey
and were examined. Those suspected of having the CHD were further
evaluated with electrocardiograph (ECG) and the diagnosis was
conﬁrmed by echocardiography.
RESULTS Of these children, 240 (boys, 43.8% and girls, 56.3%) were
identiﬁed with CHD, giving an overall prevalence of 16.5& (17.7& in
Uygur, 6.9& in Han, 11.4& in Kazak, and 38.1& in Hui Chinese,
respectively). Ventricular septal defect (VSD, 29.2%), atrial septal
defect (ASD, 20.8%), patent ductus arteriosus (PDA, 13.7%), acleisto-
cardia (13.7%), Bicuspid aortic valve (7.9%), pulmonary valve stenosis
(5.4%), tetralogy of fallot (TOF, 4.2%) were common acynotic and
cyanotic defects observed. Further, among these CHD children, 27.1%
mothers had a history of abortion, and 24% caught a cold, 10% had a
febrile illness and 6.7% received antibiotic treatment during the ﬁrst
trimester of pregnancy. The highest incidence of CHD in Hui children
at 0-6 yrs group was observed with the highest percentage of CHD
family history and consanguinity.
CONCLUSIONS The overall prevalence of CHD in four ethnical chil-
dren at age of 0-18 yr in Xinjiang was 16.5&. VSD, ASD and TOF were
the most common acyanotic and cyanotic congenital heart defects,
respectively. This study also investigated some modiﬁable risk factor
which may link to the difference in the incidence of CHD among the 4
ethnical groups.
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OBJECTIVES To study the immediate effect of injecting ATP and
nitroglycerin into coronary artery on treating Coronary Slow Flow
Angina(CSFA).
METHODS 56 patients, complaining the Angina symptom, without
stenotic lesions of epicardial major arteries and with slow ﬂow in
anterior descending branch (LAD), both of which veriﬁed by coronary
angiography, were chosen among 2842 patients undergoing coronary
angiography between May,2009 and Dec,2011. They were assigned to
ATP (31) and nitroglycerin (25), Control group (34, patients withmatched age, gender, cardiovascular risk factor and normal coronary
angiography). In the ATP group, coronary angiography was re-per-
formed after quickly injecting ATP 40ug into coronary by angio-
graphic catheter. In the nitroglycerin group, patients were dealt with
nitroglycerin 200ug. The coronary blood ﬂow was measured by TIMI
Frame Count (TFI). Obtain TFC values which recorded in liver position
in LAD slow-ﬂowing patients before and after the treatment and in
normal patients.
RESULTS 1. Basic TFC value was 76.320.6 in the ATP group,
73.818.3 in the nitroglycerin group and 28.72.6 in the control group.
2. TFC value was reduced to 26.33.2 in the ATP group after the
treatment(Compared to the value before the treatment, P <0.01.
Compared to the control group, there was no signiﬁcant difference.).
The value was reduced to 48.68.2in the nitroglycerin group after the
treatment (Compared to the value before the treatment, P <0.01. The
value was above the level of the control group, P<0.05.). The TFC
value before and after ATP treatment was obviously higher than the
nitroglycerin group (P <0.05). 3. For the 15 patients in the nitroglyc-
erin group, mean TFC value was 56.66.2, after another treatment-
injecting ATP 40ug, TFC value was reduced to 26.64.7 (In contrast to
nitroglycerin treatment, P <0.01. Compared to the control group, P
>0.05, no signiﬁcant difference).
CONCLUSIONS After ATP injection, the immediate coronary ﬂow was
normalized in patients with CSFA, superior to nitroglycerin treatment.
For the poor recovery patients after nitroglycerin treatment, giving
ATP could make coronary ﬂow reach to normal level. Obviously, the
major pathologic change of myocardial ischemia caused by CSFA was
located in microvessel.
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OBJECTIVES Unstable angina is a severe type of coronary heart dis-
ease (CHD). Dual antiplatelet therapy with aspirin and clopidogrel was
established as a cornerstone of therapy in patients with unstable
angina(UA) and stent implantation. Platelet inhibition by clopidogrel
varies from one individual to the next. We refer those treated with
clopidogrel had minimal or no alternation in platelet function as
clopidogrel resistance (CR) or high on-treatment platelet reac-
tivity(HTPR). CR is considered a failure of antiplatelet treatment.
Patients who have CR are at increased risk of major adverse cardiac
events. Recent studies have identiﬁed numerous inﬂuencing factors
for the antiplatelet effect of clopidogrel. The aim of this study was to
explore the association between platelet parameters, hs-CRP and
clopidogrel resistance.
METHODS A total of 124 unstable angina patients were enrolled in this
study from November 2013 to January 2014, in the second hospital of
Hebei Medical University. All patients had not taken aspirin or clo-
pidogrel that affect platelet function. Blood routine test, coagulation
routine test, myocardial enzyme, hepatic function, renal function,
plasma lipid, platelet aggregation rate(PAR0) were checked within one
day. A loading dose of 300mg clopidogrel and 300mg aspirin were
given to all the patients, and 75mg/d clopidogrel and 100mg/d aspirin
were maintained. Platelet aggregation rate was remeasured at 7th
day(PAR1). According to the degree of platelet aggregation inhibition
[DPAI, DPAI¼(PAR0-PAR1)/PAR0], all patients were divided into clo-
pidogrel resistance group(CR) and clopidogrel sensitive group(CS).
There were 33 cases(19 males and 14 females) in CR group, the mean
age was 61.91, while there were 91 cases(49 males and 42 females) in
CS group, and the mean age was 62.40. Platelet parameters including
platelet count(PLT), mean platelet volume(MPV), platelet distribution
width(PDW) and hypersensitive C-reactive protein(hs-CRP) levels
were compared between the two groups.
RESULTS 1. Baseline clinical characteristics: There was no signiﬁcant
difference between CR group and CS group in age, gender, BMI, his-
tory of hypertension, history of diabetes mellitus, smoking history
and drinking history.
2. Platelet parameters and hs-CRP level: The PLT, PDW, PCT levels
had no signiﬁcant difference between the CR group and the CS group.
The MPV level was signiﬁcant higher in the CR group than that of CS
group(9.311.00ﬂ vs. 8.480.96ﬂ, P<0.05). And the hs-CRP level was
signiﬁcant higher in the CR group than that of CS group(6.624.30 vs.
3.383.18, P<0.05).
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showed that MPV and hs-CRP were independent predictors of clopi-
dogrel resistance in unstable angina pectoris patients.
CONCLUSIONS MPV and hs-CRP were independent predictors of
clopidogrel resistance in patients with unstable angina.
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OBJECTIVES Catestatin is an endogenous multifunctional neuro-
endocrinepeptide. Recently, catestatin was discovered as a novel
angiogenic cytokine. The study was to investigate the associations
between endogenous catestatin and coronary collateral development
among the patients with chronic myocardial ischemia.
METHODS Thirty - eight patients with coronary artery chronic total
occlusions (CTO) (CTO group) and 38 patients with normal coronary
arteries (normal group) were enrolled in series. In the patients with
CTO, coronary collateral development was graded according to the
Rentrop score method. Rentrop score 0-1 collateral development was
regarded as poor collateral group and 2-3 collateral development was
regarded as good collateral group. Plasma catestatin level and
vascular endothelial growth factor (VEGF) were measured by ELISA
kits.
RESULTS The mean serum levels of catestatin in CTO group were
signiﬁcantly higher than that in normal group (1.971.01 vs 1.360.97
ng/ml, p ¼0.009). In the CTO group, The patients with good collateral
development had signiﬁcantly higher catestatin and VEGF levels than
those with poor collateral development (2.360.73 vs 1.611.12 ng/ml,
p ¼0.018; 425.23140.10 vs 238.48101.00 pg/mL, p <0.001). There is
a positive correlation between plasma catestatin levels and Rentrop
score (r ¼0.40, p ¼0.013) among the patients with CTO. However,
there is no correlation between plasma catestatin levels and VEGF (r ¼
-0.06, p ¼0.744). In the multiple linear regression models, plasma
catestatin was one of the independent factors of coronary collateral
development after adjustment for confounders.
CONCLUSIONS The plasma catestatin was associated with coronary
collateral developments. It may be a useful biomarker for coronary
collateral development and potential target for therapeutic angio-
genesis in patients with CTO.
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OBJECTIVES Red cell distribution width (RDW) might be a novel
biomarker that reﬂects multiple physiological impairments related to
atherosclerosis and coronary artery diseases (CAD). We conducted this
systematic review and meta-analysis to evaluate the association of
RDW between all-cause mortality and fatal/non-fatal cardiovascular
disease (CVD) events in CAD patients.
METHODS Relevant studies were searched and identiﬁed in the
MEDLINE and EMBASE databases. English-language prospective
studies that reported risk estimates for RDW and mortality/
CVD events were included. Data were extracted regarding the char-
acteristics and clinical outcomes, and a quality assessment was con-
ducted. Results were extracted for the highest versus lowest RDW
level, and meta-analyses were carried out using random effects
models.
RESULTS We identiﬁed 22 studies enrolling 80,216 participants.
The study duration ranged between 1 month and 23 years. Of the 15
studies that were included in the meta-analysis, higher RDW indi-
cated a signiﬁcant increased risk for all-cause mortality in CAD pa-
tients: pooled risk ratio (RR) 2.20 (95% CI, 1.42-3.39; P<0.0004). The
results for fatal, non-fatal and fatal/non-fatal events were: pooled RR
1.80 (95% CI, 1.35-2.41; P<0.0001), RR 1.86 (95% CI, 1.50-2.31;
P<0.00001) and RR 2.13 (95% CI, 1.20-3.77; P¼0.01). Heterogeneity
was moderately present; however, sensitivity analyses for follow-upduration, CAD subtype, or RDW as dichotomous values showed
similar results.
CONCLUSIONS The meta-analysis indicates that higher RDW levels
are associated with increased risk of mortality and CVD events in
patients with established CAD.
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OBJECTIVES Impaired myocardial reperfusion is associated with
adverse clinical outcomes in patients with ST-segment elevation
myocardial infarction (STEMI). The aim of this study was to investi-
gate the impact of admission mean platelet volume (MPV) on the
myocardial reperfusion and 30-day all-cause mortality in STEMI pa-
tients with successful epicardial coronary reperfusion after primary
percutaneous coronary intervention (PCI).
METHODS A total of 453 STEMI patients who underwent primary PCI
within 12 hours of symptoms onset and achieved TIMI 3 ﬂow at
infarct-related artery (IRA) after PCI were enrolled and divided into
two groups based on postinterventional myocardial blush grade
(MBG): those with MBG 2/3 and those with MBG 0/1. Admission MPV
was measured before coronary angiography. The primary endpoint
was all-cause mortality at 30 days.
RESULTS MPV was signiﬁcantly higher in patients with MBG 0/1 than
in patients with MBG 2/3 (10.380.98 vs 9.590.73, P<0.001). The
cumulative 30-day all-cause mortality rate was signiﬁcantly higher in
the groups with high MPV and MBG 0/1 (6.8% vs 1.5%, P¼0.005, 7.6%
vs 1.9%, P¼0.006, respectively). Multivariate logistic regression
analysis demonstrated MPV was independently associated with
postinterventional impaired myocardial reperfusion (OR 2.668, 95%
CI 2.000 to 3.559, P<0.001) and 30-day all-cause mortality (HR 1.763,
95% CI 1.009 to 3.079, P¼0.046).
CONCLUSIONS Increased MPV at admission is an independent pre-
dictor of impaired myocardial reperfusion and short-term mortality in
STEMI patients with successful epicardial coronary reperfusion after
primary PCI.GW26-e2184
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OBJECTIVES Compelling evidence from large randomized trials
demonstrates the salutary effects of ischemic postconditioning on
cardioprotection against ischemic/reperfusion injury. However,
some studies appear negative ﬁndings. Our objective was to
assess the short- and long-term effects of postconditioning in
patients presenting with evolving ST-elevation myocardial infarc-
tion (STEMI). Relevant studies from were identiﬁed through
electronic.
METHODS Relevant studies from were identiﬁed through electronic
literature search from PubMed, library of congress and EMBASE.
Studies published up to December 2014 were eligible for inclusion.
Patients older than 18 years presenting within 12 h of a ﬁrst STEMI and
eligible for angioplasty were considered for the study. Ischemic
postconditioning was performed by applying consecutive cycles of
reocclusion / reperfusion after reperfusion. The outcome include
infarct size assessed by SPECT or CMR, cardiac biomarkers and left
ventricular ejection fraction (LVEF).
